Your browser doesn't support javascript.
loading
Clinical and immunological benefits of full primary COVID-19 vaccination in individuals with SARS-CoV-2 breakthrough infections: A prospective cohort study in non-hospitalized adults.
Prelog, Martina; Jeske, Samuel D; Asam, Claudia; Fuchs, Andre; Wieser, Andreas; Gall, Christine; Wytopil, Monika; Mueller-Schmucker, Sandra M; Beileke, Stephanie; Goekkaya, Mehmet; Kling, Elisabeth; Geldmacher, Christof; Rubio-Acero, Raquel; Plank, Michael; Christa, Catharina; Willmann, Annika; Vu, Martin; Einhauser, Sebastian; Weps, Manuela; Lampl, Benedikt M J; Almanzar, Giovanni; Kousha, Kimia; Schwägerl, Valeria; Liebl, Bernhard; Weber, Beatrix; Drescher, Johannes; Scheidt, Jörg; Gefeller, Olaf; Messmann, Helmut; Protzer, Ulrike; Liese, Johannes; Hoelscher, Michael; Wagner, Ralf; Überla, Klaus; Steininger, Philipp.
Affiliation
  • Prelog M; Pediatric Rheumatology / Special Immunology, Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.
  • Jeske SD; Institute of Virology, Technical University of Munich, School of Medicine, Munich, Germany.
  • Asam C; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.
  • Fuchs A; Internal Medicine III - Gastroenterology and Infectious Diseases, University Hospital of Augsburg, Augsburg, Germany.
  • Wieser A; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany.
  • Gall C; Department of Medical Informatics, Biometry and Epidemiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Wytopil M; Institute of Clinical and Molecular Virology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Mueller-Schmucker SM; Institute of Clinical and Molecular Virology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Beileke S; Institute of Clinical and Molecular Virology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Goekkaya M; Environmental Medicine, Faculty of Medicine, University of Augsburg, Institute of Environmental Medicine Helmholtz Zentrum München, German Research Center for Environmental Health, Augsburg, Germany.
  • Kling E; Institute of Laboratory Medicine and Microbiology University Hospital Augsburg, Augsburg, Germany.
  • Geldmacher C; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany; German Centre for Infection Research (DZIF), Partner Site Munich, Munich, Germany.
  • Rubio-Acero R; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany.
  • Plank M; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany.
  • Christa C; Institute of Virology, Technical University of Munich, School of Medicine, Munich, Germany.
  • Willmann A; Institute of Virology, Technical University of Munich, School of Medicine, Munich, Germany.
  • Vu M; Institute of Virology, Technical University of Munich, School of Medicine, Munich, Germany.
  • Einhauser S; Institute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany.
  • Weps M; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.
  • Lampl BMJ; Regensburg Department of Public Health, Division of Infection Control and Prevention, Regensburg, Germany; Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
  • Almanzar G; Pediatric Rheumatology / Special Immunology, Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.
  • Kousha K; Pediatric Rheumatology / Special Immunology, Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.
  • Schwägerl V; Pediatric Infectious Diseases, Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.
  • Liebl B; Bavarian Health and Food Safety Authority (LGL), Oberschleißheim, Germany.
  • Weber B; Institute for Information Systems, University of Applied Sciences Hof, Hof, Germany.
  • Drescher J; smartlytic GmbH, Hof, Germany.
  • Scheidt J; Institute for Information Systems, University of Applied Sciences Hof, Hof, Germany.
  • Gefeller O; Department of Medical Informatics, Biometry and Epidemiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Messmann H; Internal Medicine III - Gastroenterology and Infectious Diseases, University Hospital of Augsburg, Augsburg, Germany.
  • Protzer U; Institute of Virology, Technical University of Munich, School of Medicine, Munich, Germany; Institute of Virology, Helmholtz Munich, Munich, Germany, and German Center for Infection Research, Munich partner site.
  • Liese J; Pediatric Infectious Diseases, Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.
  • Hoelscher M; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany; German Centre for Infection Research (DZIF), Partner Site Munich, Munich, Germany.
  • Wagner R; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany; Institute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany.
  • Überla K; Institute of Clinical and Molecular Virology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Steininger P; Institute of Clinical and Molecular Virology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: philipp.steininger@uk-erlangen.de.
J Clin Virol ; 170: 105622, 2024 02.
Article in En | MEDLINE | ID: mdl-38091664

Full text: 1 Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Limits: Adult / Humans Language: En Journal: J Clin Virol Journal subject: VIROLOGIA Year: 2024 Type: Article Affiliation country: Germany

Full text: 1 Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Limits: Adult / Humans Language: En Journal: J Clin Virol Journal subject: VIROLOGIA Year: 2024 Type: Article Affiliation country: Germany